KR870007900A - 태트라 사이클릭 퀴나졸리논 및 그의 제조방법 - Google Patents
태트라 사이클릭 퀴나졸리논 및 그의 제조방법 Download PDFInfo
- Publication number
- KR870007900A KR870007900A KR870001150A KR870001150A KR870007900A KR 870007900 A KR870007900 A KR 870007900A KR 870001150 A KR870001150 A KR 870001150A KR 870001150 A KR870001150 A KR 870001150A KR 870007900 A KR870007900 A KR 870007900A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- pharmaceutically acceptable
- acid addition
- addition salt
- acceptable acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (13)
- 라세미체 또는 광학적 활성형태의 다음 일반식(Ⅰ)화합물 또는 그의 약제학적으로 허용되는 산부가염.상기식에서 n는 1또는 2이고, p는 0또는 1이다.
- 제1항에 있어서, R-광학이성체 형태인 화합물.
- 제1에 있어서, n이 1이고, p가 1인 화합물.
- 제1항에 있어서, (±)-2-트리플루오로메틸-7,8,9,10,10a,11-헥사하이드로-13H-피리도[1',2':3,4] 이미다조-[2,1-b]퀴나졸린-13-온 또는 그의 약제학적으로 허용되는 산부가염인 화합물.
- 제1항에 있어서, (±)-2-트리플루오로메틸-7,8,9,10,10a,11,12,13-옥타하이드로-14H-피리도[1',2':3,4]-피리미도[2,1-b]퀴나졸린-13-온 또는 그의 약제학적으로 허용되는 산부가염인 화합물.
- 제1항에 있어서, (-)-10aR-7,8,9,10,10a,11-헥사하이드로-2-트리플루오로메틸-13H-피리도[1',2':3,4]이미다조-[2,1-b]퀴나졸린-13-온 또는 그의 약제학적으로허용되는 산부가염인 화합물.
- 제1항에 있어서, (+)-10aS-7,8,9,10,10a,11-헥사하이드로-2-트리플루오로메틸-13H-피리도[1',2':3,4]이미다조-[2,1-b]퀴나졸린-13-온 또는 그의 약제학적으로허용되는 산부가염인 화합물.
- 약제학적 제제로 사용하기 위한 제1항 내지 7항중의 어느 한항에 따르는 화합물.
- 신경안정제로 사용하기 위한 제1항내지 7항중의 어느 한항에 따르는 화합물.
- 불안해소제로 사용하기 위한 제1항내지 7항중의 어느 한항에 따르는 화합물.
- 약제학적 담체 또는 희석제와 함께 제1항내지 7항중의 어느 한 항에 따른 화합물을 함유하는 약제학적 조성물.
- 라세미체 또는 광학적 활성형태의 일반식(Ⅴ)의 화합물을 N-메틸-피롤리돈의 존재하에서 트리플루오로아세트산 또는 이의 염 및 요오드화제 1구리와 반응시키고, 수득된 화합물을 유리염기형태 또는 약제학적으로 허용되는 산부가염 형태로 회수하는 단계를 포함하는 일반식(Ⅰ)의 화합물 항는 그의 약학제적으로 허용되는 산부가염의 제조방법.상기식에서,n은 1또는 2이고,p는 0또는 1이다.
- 구조식(Ⅱ)의 화합물과 라세미체 형태의 일반식(Ⅲ)의 화합물을 반응시키고 수득된 화합물을 유리염기형태 또는 약제학적 허용되는 산부가염 형태로 회수하는 단계를 포함하는, 일반식(Ⅰ)의 화합물 또는 그의 약제학적으로 허용되는 산부가염의 제조방법.상기식에서R'는 저급알킬 또는 벤질이고,n은 1또는 2이며,p는 0또는 1이다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/829,594 US4760065A (en) | 1986-02-13 | 1986-02-13 | Trifluoromethyl substituted tetracyclic quinazolin-ones having tranquilizing activity |
US829594 | 1986-02-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR870007900A true KR870007900A (ko) | 1987-09-22 |
Family
ID=25254954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR870001150A KR870007900A (ko) | 1986-02-13 | 1987-02-12 | 태트라 사이클릭 퀴나졸리논 및 그의 제조방법 |
Country Status (22)
Country | Link |
---|---|
US (1) | US4760065A (ko) |
JP (1) | JPS62223183A (ko) |
KR (1) | KR870007900A (ko) |
AT (1) | AT390062B (ko) |
AU (1) | AU597936B2 (ko) |
BE (1) | BE1002099A3 (ko) |
CH (1) | CH671019A5 (ko) |
DE (1) | DE3702943A1 (ko) |
DK (1) | DK69787A (ko) |
ES (1) | ES2004215A6 (ko) |
FI (1) | FI870510A (ko) |
FR (1) | FR2601013A1 (ko) |
GB (1) | GB2186574B (ko) |
GR (1) | GR870232B (ko) |
HU (1) | HU198932B (ko) |
IL (1) | IL81536A0 (ko) |
IT (1) | IT1216790B (ko) |
LU (1) | LU86769A1 (ko) |
NL (1) | NL8700233A (ko) |
NZ (1) | NZ219242A (ko) |
SE (1) | SE8700566L (ko) |
ZA (1) | ZA871077B (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU665207B2 (en) * | 1991-07-29 | 1995-12-21 | Warner-Lambert Company | Quinazoline derivatives as acetylcholinesterase inhibitors |
US6133002A (en) | 1997-09-25 | 2000-10-17 | Dsm N.V. | Process for preparing optically active 2-amino-ω-oxoalkanoic acid derivatives |
EP2447239A1 (en) * | 2010-10-29 | 2012-05-02 | Saltigo GmbH | Copper-catalysed process for the production of substituted or unsubstituted trifluormethylated aryl and heteroaryl compounds |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3280117A (en) * | 1964-04-20 | 1966-10-18 | Sandoz Ag | Tricyclic quinazolinones |
US3598823A (en) * | 1969-05-28 | 1971-08-10 | Sandoz Ag | Tricyclic quinazolinones |
US3631046A (en) * | 1969-05-28 | 1971-12-28 | Sandoz Ag | Tetracyclic quinazolin-ones |
US3772230A (en) * | 1969-05-28 | 1973-11-13 | Sandoz Ag | Polyhydro-imidazo(1,5-a)pyrimidine-3(2h)-thione and pyrido(1,2-c)pyrimidine-1-thione |
US4000275A (en) * | 1969-11-24 | 1976-12-28 | Eli Lilly And Company | Immunosuppressants |
BE760013A (fr) * | 1969-12-18 | 1971-06-08 | Smith Kline French Lab | Imidazo et pyrimido -(2,1-b)quinazolines, leurs procedes de preparationet compositions pharmaceutiques en contenant |
US3868372A (en) * | 1971-07-09 | 1975-02-25 | Sandoz Ag | Organomercapto-substituted polyhydro imidazo{8 1,5-a{9 pyridenes and pyride{8 1,2-c{9 pyrimidines |
US3963720A (en) * | 1972-10-27 | 1976-06-15 | Sandoz, Inc. | Tetracyclic imidazo [2,1-b] quinazolinone derivatives |
PH17745A (en) * | 1981-09-16 | 1984-11-27 | Sandoz Ag | Trifluoromethyl substituted tricyclic quinazolinones |
US4452787A (en) * | 1981-09-16 | 1984-06-05 | Sandoz, Inc. | 1-Substituted tricyclic quinazolinones having biological activity as tranquilizers |
PH19788A (en) * | 1981-09-16 | 1986-07-02 | Sandoz Ag | 1-substituted tricyclic quinazolinones,pharmaceutical composition containing same and method of use thereof |
FR2512674B1 (fr) * | 1981-09-16 | 1986-01-10 | Sandoz Sa | Nouveaux derives tricycliques de la quinazolinone, leur preparation et medicaments contenant ces derives |
-
1986
- 1986-02-13 US US06/829,594 patent/US4760065A/en not_active Expired - Fee Related
-
1987
- 1987-01-30 NL NL8700233A patent/NL8700233A/nl not_active Application Discontinuation
- 1987-01-30 CH CH346/87A patent/CH671019A5/de not_active IP Right Cessation
- 1987-01-30 HU HU87305A patent/HU198932B/hu not_active IP Right Cessation
- 1987-01-31 DE DE19873702943 patent/DE3702943A1/de not_active Withdrawn
- 1987-02-09 FI FI870510A patent/FI870510A/fi not_active Application Discontinuation
- 1987-02-09 FR FR8701669A patent/FR2601013A1/fr active Pending
- 1987-02-10 GB GB8702938A patent/GB2186574B/en not_active Expired - Lifetime
- 1987-02-11 IL IL81536A patent/IL81536A0/xx unknown
- 1987-02-11 DK DK069787A patent/DK69787A/da not_active Application Discontinuation
- 1987-02-11 AU AU68694/87A patent/AU597936B2/en not_active Ceased
- 1987-02-11 ES ES8700334A patent/ES2004215A6/es not_active Expired
- 1987-02-11 GR GR870232A patent/GR870232B/el unknown
- 1987-02-11 NZ NZ219242A patent/NZ219242A/en unknown
- 1987-02-12 LU LU86769A patent/LU86769A1/fr unknown
- 1987-02-12 BE BE8700112A patent/BE1002099A3/fr active
- 1987-02-12 IT IT8747634A patent/IT1216790B/it active
- 1987-02-12 AT AT0029687A patent/AT390062B/de not_active IP Right Cessation
- 1987-02-12 JP JP62028370A patent/JPS62223183A/ja active Pending
- 1987-02-12 SE SE8700566A patent/SE8700566L/xx not_active Application Discontinuation
- 1987-02-12 KR KR870001150A patent/KR870007900A/ko not_active Application Discontinuation
- 1987-02-13 ZA ZA871077A patent/ZA871077B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GR870232B (en) | 1987-06-12 |
GB2186574A (en) | 1987-08-19 |
DK69787A (da) | 1987-08-14 |
NL8700233A (nl) | 1987-09-01 |
NZ219242A (en) | 1990-04-26 |
FI870510A0 (fi) | 1987-02-09 |
GB2186574B (en) | 1990-03-28 |
IT8747634A0 (it) | 1987-02-12 |
ES2004215A6 (es) | 1988-12-16 |
FI870510A (fi) | 1987-08-14 |
JPS62223183A (ja) | 1987-10-01 |
AT390062B (de) | 1990-03-12 |
DK69787D0 (da) | 1987-02-11 |
FR2601013A1 (fr) | 1988-01-08 |
IT1216790B (it) | 1990-03-14 |
SE8700566D0 (sv) | 1987-02-12 |
HUT43607A (en) | 1987-11-30 |
IL81536A0 (en) | 1987-09-16 |
CH671019A5 (ko) | 1989-07-31 |
GB8702938D0 (en) | 1987-03-18 |
SE8700566L (sv) | 1987-08-14 |
US4760065A (en) | 1988-07-26 |
BE1002099A3 (fr) | 1990-07-03 |
AU6869487A (en) | 1987-08-20 |
ZA871077B (en) | 1988-09-28 |
HU198932B (en) | 1989-12-28 |
ATA29687A (de) | 1989-08-15 |
LU86769A1 (fr) | 1987-09-15 |
DE3702943A1 (de) | 1987-08-20 |
AU597936B2 (en) | 1990-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8506677A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina. | |
KR860001110A (ko) | 항균제 ⅱ의 제법 | |
CA2331870A1 (fr) | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
ES2091212T3 (es) | Compuestos de xantina. | |
KR870011145A (ko) | 퀴놀린 카르본산 유도체의 제법 | |
ATE51617T1 (de) | Verfahren zur herstellung von 4-phenyl-pyrrolderivaten. | |
KR850004585A (ko) | 신규 아미노과니딘 유도체의 제조방법 | |
KR910014380A (ko) | 이미자조피리다진 화합물, 그의 제법 및 용도 | |
ES2033279T3 (es) | Procedimiento para preparar un compuesto a base de quinolina. | |
KR870007900A (ko) | 태트라 사이클릭 퀴나졸리논 및 그의 제조방법 | |
JPS646261A (en) | 4-thioquinazoline derivative, its production and antiulcer agent containing said derivative as active component | |
KR830004320A (ko) | 퀴나졸린 유도체의 제조방법 | |
KR900701763A (ko) | 1-아미노-5-할로게노우라실, 그의 제조방법 및 이 화합물을 유효성분으로 함유하는 중추신경억제제 | |
KR870007175A (ko) | 8α-아실아미노-에르고린 화합물의 제조방법 | |
ES532836A0 (es) | Metodo para preparar derivados de acidos b-carbolin-3-barboxilicos | |
KR880000415A (ko) | 신규한 테트라하이드로벤조티아졸 및 그의 제조방법과 용도 | |
KR860001815A (ko) | 옥타하이드로-옥사졸로[4,5-g]퀴놀린의 제조방법 | |
KR850000415A (ko) | 퀴나졸리논 유도체의 제조방법 | |
KR850005435A (ko) | 3-알콕시-2-(n-피롤리디노)-n-피리미디닐-또는 n-피라지닐 프로필아민의 제조방법 | |
EP0662475A3 (en) | Method for the preparation of 2-perfluoroalkyl-3-oxazolin-5-one | |
KR920003970A (ko) | 혈중 요산 함량의 강하 방법 | |
KR880002835A (ko) | 3-브로모-2, 6-디메톡시벤즈아미드, 이의 제조방법 및 용도 | |
KR840000496A (ko) | 요소유도체 및 그 제조방법 | |
KR840001122A (ko) | 플루오르화 디아미노-헵텐 및-헵틴 유도체의 제조방법 | |
ATE46315T1 (de) | Verfahren zur herstellung optisch aktiver chinonderivate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |